// App-Quantinova.ai

: Assessing the Immune Tumour Microenvironment (iTME) Using Multiplex Immunoflourescence Histochemistry (mIHC) Demonstrates Close Proximity of Cytotoxic T-Cells to Plasma Cells (PC) in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Researchers

Presenter

  • Slavisa Ninkovic

Principal Investigators

  • Louise E. Purton

  • Simon J Harrison

  • Hang Quach

Medical Centers

  • Department of Haematology, St. Vincent's Hospital Melbourne, Melbourne, Australia

  • Stem Cell Regulation Unit, St Vincent's Institute of Medical Research, Melbourne, Australia

  • Faculty of Medicine, University of Melbourne, St. Vincent's Hospital Melbourne, Melbourne, Australia

  • University of Melbourne, St. Vincent's Hospital, Melbourne, Australia

  • Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia

  • St. Vincent's Hospital, Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Multiple Myeloma

  • Monoclonal gammopathy

Biomarkers

  • Cluster of Differentiation 2AP

  • Programmed cell death protein 1

  • Cluster of differentiation 8A

  • Syndecan-1

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved